Inverse changes in fetal insulin-like growth factor (IGF)-1 and IGF binding protein-1 in association with higher birth weight in maternal diabetes
β Scribed by Robert S. Lindsay; J. A. Westgate; J. Beattie; N.S. Pattison; G. Gamble; L. F. J. Mildenhall; B. H. Breier; Frank D. Johnstone
- Book ID
- 108703610
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 121 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0300-0664
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background Advanced glycosylation end product (AGE) formation is a major mechanism for the development of complications in diabetes, and the possible roles of insulin-like growth factor 1 (IGF-1) and IGF binding protein 3 (IGFBP-3) are not clearly established. ## Methods We examined the associati
## Abstract Insulinβlike growth factor (IGF)βbinding proteinβ1 (IGFBPβ1), the main secretory protein of decidua that binds to IGFs and has been shown to inhibit or stimulate IGFs' bioactivities. Polymerization, one of the posttranslational modifications of IGFBPβ1, has been shown to lead to loss of
Osteogenic protein-1 (OP-1 or BMP-7) stimulates new bone formation in vivo and induces cell proliferation and differentiation of osteoblasts in vitro. Previous studies from our laboratory revealed that OP-1 led to a two-to threefold increase in steady-state insulin-like growth factor-I (IGF-I) and I